Literature DB >> 17519829

The genetics of nonalcoholic fatty liver disease.

Christoph H Osterreicher1, David A Brenner.   

Abstract

The increasing prevalence of obesity in Western countries has led to a significant increase of nonalcoholic fatty liver disease (NAFLD) over the past decades. Being part of the metabolic syndrome, NAFLD is thought to be the most frequent cause of elevated liver enzymes in the United States affecting up to one third of the population. NAFLD is also proposed to be the major cause for cryptogenic cirrhosis and hepatocellular cancer of unknown etiology, and thus, represents one of the most important problems for hepatologists in the future. However, the natural course of NAFLD is highly variable and is influenced by both environmental and genetic factors. Polymorphisms in specific genes have been proposed to increase the risk of fibrosis in patients with NAFLD. The present review article summarizes currently available data from genotype-phenotype studies and defines candidate genes that deserve future investigation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519829

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  6 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Sandra K Erickson
Journal:  J Lipid Res       Date:  2008-12-12       Impact factor: 5.922

2.  The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.

Authors:  Chuang-Yu Cao; Yu-Yuan Li; Yong-Jian Zhou; Yu-Qiang Nie; Yu-Jui Yvonne Wan
Journal:  Tohoku J Exp Med       Date:  2012-08       Impact factor: 1.848

3.  p75 Neurotrophin Receptor Regulates Energy Balance in Obesity.

Authors:  Bernat Baeza-Raja; Benjamin D Sachs; Pingping Li; Frank Christian; Eirini Vagena; Dimitrios Davalos; Natacha Le Moan; Jae Kyu Ryu; Shoana L Sikorski; Justin P Chan; Miriam Scadeng; Susan S Taylor; Miles D Houslay; George S Baillie; Alan R Saltiel; Jerrold M Olefsky; Katerina Akassoglou
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423

4.  Analysis of cytotoxic T-lymphocyte-associated antigen-4 and MMP-9 genes' methylation and their expression profiles with risk of non-alcoholic fatty liver disease.

Authors:  Dor Mohammad Kordi Tamandani; Mohammad Hashemi; Sara Shafiepour
Journal:  Indian J Hum Genet       Date:  2013-04

5.  Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD.

Authors:  Ghideon Ezaz; Hirsh D Trivedi; Margery A Connelly; Claudia Filozof; Kellie Howard; Mark L Parrish; Misung Kim; Mark A Herman; Imad Nasser; Nezam H Afdhal; Z Gordon Jiang; Michelle Lai
Journal:  Hepatol Commun       Date:  2020-03-13

6.  Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.

Authors:  Sabine Siegert; Zhonghao Yu; Rui Wang-Sattler; Thomas Illig; Jerzy Adamski; Jochen Hampe; Susanna Nikolaus; Stefan Schreiber; Michael Krawczak; Michael Nothnagel; Ute Nöthlings
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.